Fig. 2: Kaplan–Meier survival curves for patients in the validation cohort based on lymph node status. | Modern Pathology

Fig. 2: Kaplan–Meier survival curves for patients in the validation cohort based on lymph node status.

From: Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis

Fig. 2

Lymph node-negative patients: distant recurrence-free survival (a) and breast cancer-specific survival (b). Lymph node-positive patients: distant recurrence-free survival (c) and breast cancer-specific survival (d).

Back to article page